The brain health devices market has seen considerable growth due to a variety of factors.
• The market for brain health devices has experienced robust growth in previous years. Projected growth is from $11.07 billion in 2024 to $11.9 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.
The growth historically has been driven by factors such as an increase in neurological disorders, an aging population, expansion of diagnostic centers and hospitals, heightened patient awareness of neurological diseases, and increased government support.
The brain health devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market for brain health devices is predicted to witness significant expansion in the upcoming years, with an expected growth to $15.73 billion in 2029, at a compound annual growth rate (CAGR) of 7.2%.
This surge during the forecast period can be credited to enhanced reimbursement policies, escalation in the occurrence of sleep disorders, amplified focus on personalized medicine, increasing popularity of non-invasive processes, and an upswing in regulatory approvals for innovative devices. Foreseeable trends for the forecast period comprise technological advancements, incorporation of artificial intelligence, inclusion of mobile health applications, the creation of tailor-made brain health products, and progress in brain monitoring devices.
The brain health devices market is anticipated to expand due to the escalating occurrence of neurological disorders. These conditions affect the nervous system, including the brain, spinal cord, and nerves, leading to various sensory, cognitive, and motor-related dysfunctions. A burgeoning elderly population and the growing incidence of chronic diseases such as diabetes and hypertension are the primary culprits contributing to the rise in neurological disorders. Other contributing factors include environmental and lifestyle influences, advancements in diagnostic techniques, and genetic predispositions. Brain health devices, which monitor brain activity and provide targeted therapies, are used to manage symptoms, boost cognitive function, and improve patient outcomes. For example, a report by the Alzheimer's Association, a US-based nonprofit health organization, stated that in 2022, 6.5 million Americans aged 65 and older were diagnosed with Alzheimer's dementia. This number escalated to 6.9 million by April 2024. Hence, the escalating occurrence of neurological disorders is fuelling the growth of the brain health devices market.
The brain health devices market covered in this report is segmented –
1) By Device Type: Magnetic Resonance Imaging, Magneto Encephalogram, Computed Tomography, Transcranial Doppler Device, Other Device Types
2) By Procedure: Invasive, Non-Invasive
3) By Application: Sleep Disorders, Accidental Injuries, Alzheimer's Disease, Epilepsy, Stroke, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Imaging Centers, Homecare Settings, Assisted Living Facilities, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Functional MRI (fMRI), Diffusion Tensor Imaging (DTI), MRI Spectroscopy
2) By Magnetoencephalogram (MEG): Whole-Head MEG Systems, Cooled MEG Systems
3) By Computed Tomography (CT): Standard CT Scanners, CT Angiography, High-Resolution CT Scanners
4) By Transcranial Doppler Device: Handheld Transcranial Doppler Devices, Portable Transcranial Doppler Devices
5) By Other Device Types: Electroencephalogram (EEG) Devices, Positron Emission Tomography (PET) Scanners, Near-Infrared Spectroscopy (NIRS) Devices
Leading corporations in the brain health devices sector are prioritizing the modernization of noninvasive and pliable monitoring options, like brain monitoring systems, to heighten diagnostic precision, boost patient results, and optimize neurological condition management. Brain monitoring systems provide relentless, non-invasive scrutiny of brain activities, thus allowing early identification and handling of neurological disorders. For example, Neurosteer Inc., an American firm that manufactures medical equipment, garnered clearance from the Food and Drug Administration (FDA) in November 2022 for their single-channel electroencephalogram (EEG) brain monitoring platform. This approval permits this adaptable system to be configured for usage in diverse clinical surroundings. The platform enables continuous brain monitoring in intensive care units (ICUs) for vital interventions and aids in the early recognition of pre-symptomatic cognitive decline, including disorders like Alzheimer's, Parkinson's, and dementia, within physician practices.
Major companies operating in the brain health devices market are:
• Johnson & Johnson Services Inc.
• Medtronic plc
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Boston Scientific Corporation
• electroCore Inc.
• Masimo Corporation
• Integra LifeSciences Corporation
• LivaNova plc
• Natus Medical Incorporated
• Cadwell Industries Inc.
• NeuroSky Inc.
• Neuropace Inc.
• Compumedics Limited
• Magstim Co. Ltd.
• Mindmaze SA
• Brain Products GmbH
• Emotiv Inc.
• Electrical Geodesics Inc.
• BrainScope Company Inc.
• Soterix Medical Inc.
• Advanced Brain Monitoring Inc.
• Bio-Signal Group Corp.
• Cognionics Inc
North America was the largest region in the brain health devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain health devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.